Atrial Fibrillation is a Risk Factor for Worse Outcomes in Patients with End Stage Liver Disease.

导出 LinkOut

翻译打印收藏纠错

第一作者： Zia Khan,Muhammad

第一单位： Department of Medicine, West Virginia University, Morgantown, WV, USA.

作者： Zia Khan,Muhammad ^[1] ; U Khan,Muhammad ^[1] ; U Khan,Safi ^[1] ; Alharbi,Anas ^[1] ; Osman,Mohammed ^[2] ; Pratik,Agrawal ^[2] ; Mina,M Benjamin ^[2] ; Kinjan,Patel ^[2] ; Sudarshan,Balla ^[2] ; Muhammad Bilal,Munir ^[2]

作者单位： Department of Medicine, West Virginia University, Morgantown, WV, USA. ^[1] Division of Cardiovascular Medicine, West Virginia University Heart and Vascular Institute, Morgantown, WV, USA. ^[2] Section of Electrophysiology, Division of Cardiovascular Medicine, University of California San Diego, La Jolla, CA, USA. ^[3]

关键词 Atrial fibrillation End-stage liver disease Outcomes

DOI 10.4022/jafib.2248

PMID 32435353

发布时间 2022-04-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of atrial fibrillation

2248页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Atrial Fibrillation is a Risk Factor for Worse Outcomes in Patients with End Stage Liver Disease.

Journal of atrial fibrillation

相似文献

Journal of atrial fibrillation

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Atrial Fibrillation is a Risk Factor for Worse Outcomes in Patients with End Stage Liver Disease.

Journal of atrial fibrillation

相似文献

Journal of atrial fibrillation

相关期刊

检索历史清除